Medtronic PLC
NYSE:MDT

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
NYSE:MDT
Watchlist
Price: 81.68 USD 0.34%
Market Cap: 104.8B USD
Have any thoughts about
Medtronic PLC?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MDT Price Targets Summary
Medtronic PLC

Wall Street analysts forecast MDT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDT is 97.42 USD with a low forecast of 82.82 USD and a high forecast of 116.68 USD.

MDT Lowest Forecast
Wall Street Target
82.82 USD
1% Upside
MDT Average Forecast
Wall Street Target
97.42 USD
19% Upside
MDT Highest Forecast
Wall Street Target
116.68 USD
43% Upside
Lowest
Price Target
82.82 USD
1% Upside
Average
Price Target
97.42 USD
19% Upside
Highest
Price Target
116.68 USD
43% Upside

MDT Last Price Targets
Medtronic PLC

The latest public price target was made on Oct 15, 2024 by David Rescott from Robert W. Baird , who expects MDT stock to rise by 18% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David Rescott
Robert W. Baird
96 USD
Upside 18%
2 months ago
Oct 15, 2024
Medtronic, Inc. (MDT) PT Raised to $96 at Baird
StreetInsider
Shagun Singh
RBC Capital
105 USD
Upside 29%
2 months ago
Oct 10, 2024
Medtronic upgraded to Outperform from Sector Perform at RBC Capital
TheFly
Vijay Kumar
Evercore ISI
104 USD
Upside 27%
2 months ago
Oct 1, 2024
Medtronic target raised, added to 'Tactical Outperform' list at Evercore ISI
TheFly
Joanne Wuensch
Citigroup
92 USD
Upside 13%
2 months ago
Oct 1, 2024
Medtronic price target raised to $92 from $85 at Citi
TheFly
David Roman
Goldman Sachs
82 USD
Upside 0%
4 months ago
Aug 21, 2024
Goldman Sachs Reiterates Sell Rating on Medtronic, Inc. (MDT)
StreetInsider
Steven Lichtman
Oppenheimer
94 USD
Upside 15%
4 months ago
Aug 21, 2024
Medtronic, Inc. (MDT) PT Raised to $94 at Oppenheimer
StreetInsider
Anthony Petrone
Mizuho Securities
98 USD
Upside 20%
4 months ago
Aug 21, 2024
Medtronic, Inc. (MDT) PT Raised to $98 at Mizuho
StreetInsider
Larry Biegelsen
Wells Fargo
106 USD
Upside 30%
4 months ago
Aug 21, 2024
Medtronic price target raised to $106 from $105 at Wells Fargo
TheFly
Matt O'Brien
Piper Sandler
90 USD
Upside 10%
4 months ago
Aug 21, 2024
Medtronic price target raised to $90 from $85 at Piper Sandler
TheFly
Rick Wise
Stifel Nicolaus
87 USD
Upside 7%
4 months ago
Aug 20, 2024
Medtronic price target raised to $87 from $85 at Stifel
TheFly
Larry Biegelsen
Wells Fargo
105 USD
Upside 29%
7 months ago
May 24, 2024
Medtronic, Inc. (MDT) PT Raised to $105 at Wells Fargo
StreetInsider
David Rescott
Robert W. Baird
87 USD
Upside 7%
7 months ago
May 24, 2024
Medtronic, Inc. (MDT) PT Lowered to $87 at Baird
StreetInsider
Shagun Singh
RBC Capital
92 USD
Upside 13%
7 months ago
May 24, 2024
RBC Capital Reiterates Sector Perform Rating on Medtronic, Inc. (MDT)
StreetInsider
Richard Newitter
Truist Financial
88 USD
Upside 8%
7 months ago
May 24, 2024
Medtronic, Inc. (MDT) PT Lowered to $88 at Truist Securities
StreetInsider
Rick Wise
Stifel Nicolaus
100 USD
Upside 22%
7 months ago
May 23, 2024
Stifel Reiterates Buy Rating on Medtronic, Inc. (MDT)
StreetInsider
Larry Biegelsen
Wells Fargo
102 USD
Upside 25%
1 year ago
Sep 13, 2023
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
Benzinga
David Rescott
Robert W. Baird
90 USD
Upside 10%
1 year ago
Aug 10, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Larry Biegelsen
Wells Fargo
100 USD
Upside 22%
1 year ago
Jul 12, 2023
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
Benzinga
Show More Price Targets
Show Less Price Targets
David Rescott
Robert W. Baird
Price Target 96 USD
Upside/Downside 18%
View Source
Shagun Singh
RBC Capital
Price Target 105 USD
Upside/Downside 29%
View Source
Vijay Kumar
Evercore ISI
Price Target 104 USD
Upside/Downside 27%
View Source
Joanne Wuensch
Citigroup
Price Target 92 USD
Upside/Downside 13%
View Source
David Roman
Goldman Sachs
Price Target 82 USD
Upside/Downside 0%
View Source
Steven Lichtman
Oppenheimer
Price Target 94 USD
Upside/Downside 15%
View Source
Anthony Petrone
Mizuho Securities
Price Target 98 USD
Upside/Downside 20%
View Source
Larry Biegelsen
Wells Fargo
Price Target 106 USD
Upside/Downside 30%
View Source
Matt O'Brien
Piper Sandler
Price Target 90 USD
Upside/Downside 10%
View Source
Rick Wise
Stifel Nicolaus
Price Target 87 USD
Upside/Downside 7%
View Source
Larry Biegelsen
Wells Fargo
Price Target 105 USD
Upside/Downside 29%
View Source
David Rescott
Robert W. Baird
Price Target 87 USD
Upside/Downside 7%
View Source
Shagun Singh
RBC Capital
Price Target 92 USD
Upside/Downside 13%
View Source
Richard Newitter
Truist Financial
Price Target 88 USD
Upside/Downside 8%
View Source
Rick Wise
Stifel Nicolaus
Price Target 100 USD
Upside/Downside 22%
View Source
Larry Biegelsen
Wells Fargo
Price Target 102 USD
Upside/Downside 25%
View Source
David Rescott
Robert W. Baird
Price Target 90 USD
Upside/Downside 10%
View Source
Larry Biegelsen
Wells Fargo
Price Target 100 USD
Upside/Downside 22%
View Source
Show More Price Targets
Show Less Price Targets
Medtronic PLC Competitors:
Price Targets
M
301363
Mehow Innovative Ltd
24% Upside
300298
Sinocare Inc
34% Upside
PRM
Prim SA
73% Upside
HOLX
Hologic Inc
22% Upside
M
301363
Mehow Innovative Ltd
24% Upside
300298
Sinocare Inc
34% Upside
PRM
Prim SA
73% Upside
HOLX
Hologic Inc
22% Upside
ABT
Abbott Laboratories
16% Upside
S
605186
Shanghai General Healthy Information and Technology Co Ltd
16% Upside
MOVE
Medacta Group SA
35% Upside
OWLT
Owlet Inc
236% Upside

Revenue
Forecast

Revenue Estimate
Medtronic PLC

For the last 8 years the compound annual growth rate for Medtronic PLC's revenue is 1%. The projected CAGR for the next 3 years is 5%.

1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medtronic PLC

For the last 8 years the compound annual growth rate for Medtronic PLC's operating income is 0%. The projected CAGR for the next 3 years is 17%.

0%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medtronic PLC

For the last 8 years the compound annual growth rate for Medtronic PLC's net income is 0%. The projected CAGR for the next 3 years is 30%.

0%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-36%
Average Miss
What are analyst estimates?

See Also

Summary
MDT intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDT stock valuation using valuation multiples.
Wall Street Estimates
MDT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDT's stock price target?
Price Target
97.42 USD

According to Wall Street analysts, the average 1-year price target for MDT is 97.42 USD with a low forecast of 82.82 USD and a high forecast of 116.68 USD.

What is Medtronic PLC's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Medtronic PLC's revenue is 1%. The projected CAGR for the next 3 years is 5%.

What is Medtronic PLC's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Medtronic PLC's operating income is 0%. The projected CAGR for the next 3 years is 17%.

What is Medtronic PLC's Net Income forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Medtronic PLC's net income is 0%. The projected CAGR for the next 3 years is 30%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.